245 related articles for article (PubMed ID: 9683000)
1. In vivo muscarinic cholinergic mediated effects of Lu 25-109, a M1 agonist and M2/M3 antagonist in vitro.
Sánchez C; Arnt J; Didriksen M; Dragsted N; Moltzen Lenz S; Matz J
Psychopharmacology (Berl); 1998 Jun; 137(3):233-40. PubMed ID: 9683000
[TBL] [Abstract][Full Text] [Related]
2. Discriminative stimulus properties of the muscarinic receptor agonists Lu 26-046 and O-Me-THPO in rats: evidence for involvement of different muscarinic receptor subtypes.
Arnt J; Lembøl HL; Meier E; Pedersen H
Eur J Pharmacol; 1992 Jul; 218(1):159-69. PubMed ID: 1397027
[TBL] [Abstract][Full Text] [Related]
3. Xanomeline compared to other muscarinic agents on stimulation of phosphoinositide hydrolysis in vivo and other cholinomimetic effects.
Bymaster FP; Carter PA; Peters SC; Zhang W; Ward JS; Mitch CH; Calligaro DO; Whitesitt CA; DeLapp N; Shannon HE; Rimvall K; Jeppesen L; Sheardown MJ; Fink-Jensen A; Sauerberg P
Brain Res; 1998 Jun; 795(1-2):179-90. PubMed ID: 9622623
[TBL] [Abstract][Full Text] [Related]
4. Lu 25-109, a combined m1 agonist and m2 antagonist, modulates regulated processing of the amyloid precursor protein of Alzheimer's disease.
Müller D; Wiegmann H; Langer U; Moltzen-Lenz S; Nitsch RM
J Neural Transm (Vienna); 1998; 105(8-9):1029-43. PubMed ID: 9869334
[TBL] [Abstract][Full Text] [Related]
5. SB 202026: a novel muscarinic partial agonist with functional selectivity for M1 receptors.
Loudon JM; Bromidge SM; Brown F; Clark MS; Hatcher JP; Hawkins J; Riley GJ; Noy G; Orlek BS
J Pharmacol Exp Ther; 1997 Dec; 283(3):1059-68. PubMed ID: 9399977
[TBL] [Abstract][Full Text] [Related]
6. The role of muscarinic cholinergic receptors in the discriminative stimulus properties of clozapine in rats.
Kelley BM; Porter JH
Pharmacol Biochem Behav; 1997 Aug; 57(4):707-19. PubMed ID: 9258998
[TBL] [Abstract][Full Text] [Related]
7. Activation of cerebral function by CS-932, a functionally selective M1 partial agonist: neurochemical characterization and pharmacological studies.
Iwata N; Kozuka M; Hara T; Kanek T; Tonohiro T; Sugimoto M; Niitsu Y; Kondo Y; Yamamoto T; Sakai J; Nagano M
Jpn J Pharmacol; 2000 Nov; 84(3):266-80. PubMed ID: 11138727
[TBL] [Abstract][Full Text] [Related]
8. Postsynaptic integration of cholinergic and dopaminergic signals on medium-sized GABAergic projection neurons in the neostriatum.
Harsing LG; Zigmond MJ
Brain Res Bull; 1998 Apr; 45(6):607-13. PubMed ID: 9566505
[TBL] [Abstract][Full Text] [Related]
9. Activation of muscarinic M3-like receptors and beta-adrenoceptors, but not M2-like muscarinic receptors or alpha-adrenoceptors, directly modulates corticostriatal neurotransmission in vitro.
Niittykoski M; Ruotsalainen S; Haapalinna A; Larson J; Sirviö J
Neuroscience; 1999 Apr; 90(1):95-105. PubMed ID: 10188937
[TBL] [Abstract][Full Text] [Related]
10. Role of specific muscarinic receptor subtypes in cholinergic parasympathomimetic responses, in vivo phosphoinositide hydrolysis, and pilocarpine-induced seizure activity.
Bymaster FP; Carter PA; Yamada M; Gomeza J; Wess J; Hamilton SE; Nathanson NM; McKinzie DL; Felder CC
Eur J Neurosci; 2003 Apr; 17(7):1403-10. PubMed ID: 12713643
[TBL] [Abstract][Full Text] [Related]
11. Effects of pilocarpine hydrochloride and cevimeline on submandibular/sublingual salivation in rat xerostomia model produced by X-ray irradiation.
Omori Y; Asari T; Maruyama K; Kusama H; Kojima M; Shibata N
Arzneimittelforschung; 2003; 53(5):342-50. PubMed ID: 12854361
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and structure-activity studies of a series of 1-oxa-2,8-diazaspiro[4.5]decan-3-ones and related compounds as M1 muscarinic agonists.
Tsukamoto S; Nagaoka H; Igarashi S; Wanibuchi F; Hidaka K; Tamura T
Chem Pharm Bull (Tokyo); 1995 Sep; 43(9):1523-9. PubMed ID: 7586076
[TBL] [Abstract][Full Text] [Related]
13. Novel alkoxy-oxazolyl-tetrahydropyridine muscarinic cholinergic receptor antagonists.
Shannon HE; Bymaster FP; Hendrix JC; Quimby SJ; Mitch CH
Psychopharmacology (Berl); 1995 Jan; 117(2):208-15. PubMed ID: 7753969
[TBL] [Abstract][Full Text] [Related]
14. Functional characterization of peripheral muscarinic subtypes in anesthetized cats.
Koss MC
Life Sci; 1997; 61(2):217-27. PubMed ID: 9217280
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of phenylacetyl derivatives having low central nervous system permeability as potent and selective M2 muscarinic receptor antagonists.
Watanabe T; Kakefuda A; Tanaka A; Takizawa K; Hirano S; Shibata H; Yamagiwa Y; Yanagisawa I
Chem Pharm Bull (Tokyo); 1998 Jan; 46(1):53-68. PubMed ID: 9468637
[TBL] [Abstract][Full Text] [Related]
16. In primary neuronal cultures muscarinic m1 and m3 receptor mRNA levels are regulated by agonists, partial agonists and antagonists.
Brusa R; Gamalero SR; Genazzani E; Eva C
Eur J Pharmacol; 1995 Mar; 289(1):9-16. PubMed ID: 7781716
[TBL] [Abstract][Full Text] [Related]
17. M1 receptor agonist activity is not a requirement for muscarinic antinociception.
Sheardown MJ; Shannon HE; Swedberg MD; Suzdak PD; Bymaster FP; Olesen PH; Mitch CH; Ward JS; Sauerberg P
J Pharmacol Exp Ther; 1997 May; 281(2):868-75. PubMed ID: 9152396
[TBL] [Abstract][Full Text] [Related]
18. Evidence for Classical Cholinergic Toxicity Associated with Selective Activation of M1 Muscarinic Receptors.
Alt A; Pendri A; Bertekap RL; Li G; Benitex Y; Nophsker M; Rockwell KL; Burford NT; Sum CS; Chen J; Herbst JJ; Ferrante M; Hendricson A; Cvijic ME; Westphal RS; O'Connell J; Banks M; Zhang L; Gentles RG; Jenkins S; Loy J; Macor JE
J Pharmacol Exp Ther; 2016 Feb; 356(2):293-304. PubMed ID: 26582730
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of blood-brain barrier passage of a muscarine M1 agonist and a series of analogous tetrahydropyridines measured by in vivo microdialysis.
Sveigaard HH; Dalgaard L
Pharm Res; 2000 Jan; 17(1):70-6. PubMed ID: 10714611
[TBL] [Abstract][Full Text] [Related]
20. The involvement of muscarinic receptor subtypes in the mediation of hypothermia, tremor, and salivation in male mice.
Sánchez C; Lembøl HL
Pharmacol Toxicol; 1994 Jan; 74(1):35-9. PubMed ID: 8159635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
